Managing Intrathecal Drug Delivery (ITDD) in Cancer Patients

被引:10
|
作者
Shah, Rajiv [1 ]
Baqai-Stern, Aisha [2 ]
Gulati, Amitabh [2 ]
机构
[1] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care, Board Certified Anesthesiol & Pain Management, M308, New York, NY 10065 USA
关键词
Intrathecal drug delivery; Intrathecal medications; Cancer pain; Neuraxial trial; CHRONIC PAIN; MANAGEMENT; RECOMMENDATIONS; SELECTION; THERAPY; SYSTEM; IMPACT;
D O I
10.1007/s11916-015-0488-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pain is a commonly reported symptom in cancer patients. Patients with cancer pain often fail conservative medical management or have significant side effects to systemic medications. The implantation of an intrathecal drug delivery (ITDD) system may be the most effective treatment option for these patients and can improve their quality of life. This article aims to discuss the choice of intrathecal medications for patients suffering from intractable cancer pain, the management of ITDD throughout a patient's disease course, and the management of complications related to the ITDD system and intrathecal medications.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Consensus Guidelines for the Selection and Implantation of Patients With Noncancer Pain for Intrathecal Drug Delivery
    Deer, Timothy R.
    Smith, Howard S.
    Cousins, Michael
    Doleys, Daniel M.
    Levy, Robert M.
    Rathmell, James P.
    Staats, Peter S.
    Wallace, Mark
    Webster, Lynn R.
    PAIN PHYSICIAN, 2010, 13 (03) : E175 - E213
  • [42] Best Practices for Intrathecal Drug Delivery for Pain
    Prager, Joshua
    Deer, Timothy
    Levy, Robert
    Bruel, Brian
    Buchser, Eric
    Caraway, David
    Cousins, Michael
    Jacobs, Marilyn
    McGlothlen, Gail
    Rauck, Richard
    Staats, Peter
    Stearns, Lisa
    NEUROMODULATION, 2014, 17 (04): : 354 - 372
  • [43] Safety and efficacy of intrathecal drug delivery for pain
    Jones, R. Carter W., III
    Moeller-Bertram, Tobias
    Wallace, Mark S.
    PAIN MANAGEMENT, 2012, 2 (01) : 55 - 61
  • [44] Catheter implant systems for intrathecal drug delivery
    Penn, RD
    JOURNAL OF NEUROSURGERY, 1996, 84 (04) : 713 - 713
  • [45] Intrathecal drug delivery in the management of chronic pain
    Van Zundert, Jan
    Rauck, Richard
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2023, 37 (02) : 157 - 169
  • [46] CATHETER SYSTEMS FOR INTRATHECAL DRUG-DELIVERY
    PENN, RD
    YORK, MM
    PAICE, JA
    JOURNAL OF NEUROSURGERY, 1995, 83 (02) : 215 - 217
  • [47] Efficacy and safety of single and double catheter intrathecal drug delivery systems in patients with refractory neck and abdominal cancer pain
    Li, Qin
    Wang, Huaiming
    Li, Qiju
    Xu, Maoxia
    Zhong, Bo
    Hu, Xin
    Zou, Jiang
    Feng, Pengjiu
    Zhang, Aimin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [48] Health Services Utilization and Payments in Patients with Cancer Pain: A Comparison of Intrathecal Drug Delivery versus Conventional Medical Management
    Hinnenthal, Jennifer
    Stearns, Lisa
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (02) : 503 - 504
  • [49] Prepontine Cistern Intrathecal Targeted Drug Delivery for Cancer-Related Craniofacial Pain
    Zou, Dingquan
    Zhang, Wei
    Wang, Yaping
    PAIN MEDICINE, 2021, 22 (12) : 3112 - 3114
  • [50] Plain radiography in patients treated with intrathecal drug delivery using an implantable pump device
    Elmar M. Delhaas
    Biswadjiet S. Harhangi
    Sander P. G. Frankema
    Frank J. P. M. Huygen
    Aad van der Lugt
    Insights into Imaging, 2017, 8 : 499 - 511